Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis

被引:34
作者
Wang, Hui [1 ]
Wei, Xiuqi [1 ]
Wu, Bian [2 ]
Su, Jingyu [1 ]
Tan, Wenbin [3 ]
Yang, Kunyu [2 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Lab Med, Wuhan 430022, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430023, Hubei, Peoples R China
[3] Univ South Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA
来源
CANCER MANAGEMENT AND RESEARCH | 2019年 / 11卷
基金
中国国家自然科学基金;
关键词
tumor-educated platelet; miRNA; liquid biopsy; diagnostic value; nasopharyngeal carcinoma; CELLS PROLIFERATION; MESSENGER-RNA; SUPPRESSES; CANCER; INVASION; EXPRESSION; MIRNA; PROGRESSION; APOPTOSIS; MIGRATION;
D O I
10.2147/CMAR.S195654
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Nasopharyngeal carcinoma (NPC) is the common malignant tumor of nasopharynx in southern China and other southeastern Asian countries. MicroRNAs (miRNAs) have been shown to play important roles in carcinogenesis. Recently, miR-34c-3p and miR-18a-5p have been found to be involved in carcinogenesis of NPC. Furthermore, platelets in NPC patients may acquire RNAs from NPC cells and turn into "tumor-educated platelet (TEP)", which may serve as potential biomarkers for a diagnosis of NPC. However, the expression profiles of TEP miR-34c-3p and miR-18a-5p in NPC patients and their diagnostic values are yet to be determined. Aims: To investigate expression levels of TEP miR-34c-3p and miR-18a-5p and determine their diagnostic values for NPC. Materials and methods: Relative quantitative real-time PCR was used to determine the expression levels of TEP miR-34c-3p and miR-18a-5p in NPC patients (n=54) as compared to normal subjects (n=36). The receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic values of TEP miR-34c-3p and miR-18a-5p for NPC. Results: The expression levels of TEP miR-34c-3p and miR-18a-5p were significantly higher in NPC patients as compared to healthy subjects. The ROC analysis showed that the area under the ROC curve (AUC), sensitivity, specificity and accuracy for TEP miR-34c-3p, miR-18a-5p, or a combination of both miRNAs for NPC diagnostic tests were 0.952, 94.44%, 86.11%, 91.11%, or 0.884, 85.19%, 86.11%, 85.55%, or 0.954, 92.59%, 86.11%, 90.00%, respectively. No correlation was found between expression levels of TEP miR-34c-3p or miR-18a-5p and patients' demographic variables and their NPC tumor/node/metastasis stages. The positive rates of TEP miR-34c-3p and miR-18a-5p for NPC diagnosis were 93.8% and 87.5%, respectively, which were significantly higher than Epstein-Barr virus DNA with a positive rate of 66.7%. Conclusion: The expression levels of TEP miR-34c-3p and miR-18a-5p are upregulated in NPC, rendering a significant clinical value for NPC diagnosis. The TEP miRNAs might serve as a novel type of liquid biopsies for NPC diagnosis.
引用
收藏
页码:3351 / 3360
页数:10
相关论文
共 50 条
  • [31] Serum miR-34a-5p and miR-199a-3p as new biomarkers of neonatal sepsis
    Abdelaleem, Omayma O.
    Mohammed, Shereen Rashad
    El Sayed, Hassan S.
    Hussein, Sherin Khamis
    Ali, Doaa Y.
    Abdelwahed, Mostafa Y.
    Gaber, Sylvana N.
    Hemeda, Nada F.
    Abd El-Hmid, Rehab G.
    PLOS ONE, 2022, 17 (01):
  • [32] MiR-205-5p and MiR-222-3p as Potential Biomarkers of Endometrial Cancer
    Bogaczyk, Anna
    Potocka, Natalia
    Paszek, Sylwia
    Skrzypa, Marzena
    Zuchowska, Alina
    Kosny, Michal
    Kluz-Barlowska, Marta
    Wrobel, Andrzej
    Wrobel, Jan
    Zawlik, Izabela
    Kluz, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [33] The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling
    Ji, Yuqing
    Wang, Man
    Li, Xueshen
    Cui, Fusheng
    YONSEI MEDICAL JOURNAL, 2019, 60 (04) : 336 - 345
  • [34] Identification of serum exosomal miR-98-5p, miR-183-5p, miR-323-3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms
    Yang, Qi
    Wei, Bo
    Peng, Chuangang
    Wang, Le
    Li, Chang
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2022, 70 (01)
  • [35] miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3
    Zhou, Hongyu
    Zhang, Nana
    OPEN MEDICINE, 2022, 17 (01): : 1241 - 1251
  • [36] PBMCs to Stress-Associated miR-18a-5p and miR-22-3p Ratios as New Indicators of Metabolic Syndrome
    Huang, Yuxiang
    Zhao, Liqin
    Yan, Yuxiang
    Chen, Jingyu
    Liu, Pengfei
    Xv, Weicheng
    Qian, Ge
    Li, Chijian
    Liang, Shiyi
    Zou, Hequn
    Li, Yongqiang
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [37] Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma
    Zehra Oksuz
    Mehmet Sami Serin
    Engin Kaplan
    Aylin Dogen
    Seda Tezcan
    Gonul Aslan
    Gurol Emekdas
    Orhan Sezgin
    Engin Altintas
    Eyup Naci Tiftik
    Molecular Biology Reports, 2015, 42 : 713 - 720
  • [38] The potential of five c-miRNAs as serum biomarkers for Late-Onset Alzheimer ' s disease diagnosis: miR-10a-5p, miR-29b-2-5p, miR-125a-5p, miR-342-3p, and miR-708-5p
    de Lourdes Signorini-Souza, Isadora
    Tureck, Luciane Viater
    Batistela, Meire Silva
    de Almeida, Rodrigo Coutinho
    de Almeida, Sergio Monteiro
    Furtado-Alle, Lupe
    Souza, Ricardo Lehtonen Rodrigues
    BRAIN RESEARCH, 2024, 1841
  • [39] Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers
    Zheng, Xiao-Hui
    Cui, Cui
    Ruan, Hong-Lian
    Xue, Wen-Qiong
    Zhang, Shao-Dan
    Hu, Ye-Zhu
    Zhou, Xin-Xi
    Jia, Wei-Hua
    CHINESE JOURNAL OF CANCER, 2014, 33 (07) : 330 - 338
  • [40] miR-7111-5p and miR6870-5p may be Potential Biomarkers for Oral Squamous Cell Carcinoma
    Saraei, Mona
    Garajei, Ata
    Jamshidian, Faranak
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2021, 36 (03): : 252 - 258